These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Canertinib pfizer.
    Author: Galmarini CM.
    Journal: IDrugs; 2004 Jan; 7(1):58-63. PubMed ID: 14730468.
    Abstract:
    Canertinib, a water-soluble, orally available analog of PD-169414 (Pfizer Inc), is an EGFR tyrosine kinase inhibitor under development by Pfizer Inc as a potential treatment for cancer.
    [Abstract] [Full Text] [Related] [New Search]